Firefly Neuroscience, Inc. (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its acceptance into the NVIDIA Connect program. Firefly expects to use the powerful new tools and resources provided through this prestigious program to help support a new strategic initiative to build a proprietary foundation model of the human brain using its FDA-cleared Brain Network Analytics (“BNA™”) technology platform, which harnesses Resting EEG and Cognitive EEG (ERP) data.
NVIDIA Connect brings together NVIDIA’s (NASDAQ:NVDA) advanced software development resources, industry-leading frameworks and software development kits, and global ecosystem to help fuel the growth of member companies and expand the capabilities of their software development teams. Benefits include technical training and engineering guidance to support the development of products, and discounts on
NVIDIA software and hardware to accelerate development and increase efficiency.
“We are honored and excited to be among the select few medtech companies – big, medium or small – to be accepted into the prestigious NVIDIA Connect program,” said Greg Lipschitz, Executive Chairman of Firefly.
Firefly is an Artificial Intelligence company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders
AIFF shares hiked $1.33, or 42.9%, to $4.43, while those for NVDA gathered 38 cents to $133.95.
